Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by scarlet1967on Feb 09, 2021 1:10pm
119 Views
Post# 32514277

RE:RE:TH is dead money

RE:RE:TH is dead money I bought Aphria a couple years ago at one point I was down 80k, yesterday I sold my position with over 300 k profit( although I wish I would have sold today since it has gained some %25 since my exit price) but the sector is volatile and with two other cannabis companies reporting their earnings this week I didn't want to wait.
The reason I hanged on was purely this company was EBITDA positive for few last quarters properly the only company in the industry, also US were warming up to federally legalized Cannabis which got a boost by a pro cannabis new administration in the US. Who knows it might even double from here but I was/am happy with my profit and moving on. Point is you can't invest and look at daily, monthly even yearly charts, I rather look at fundamentals over mid to long term and THTX with promising  R&D programs. growing sales and extremely oversold in my opinion is a buy.
I don't care if it loose or gain some %20, %30 ... in the short term as I am not a trader never been never will be. 
<< Previous
Bullboard Posts
Next >>